This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsuzaki, K. Articles by Suda, T. Search for Related Content PubMed PubMed Citation Articles by Matsuzaki, K. Articles by Suda, T.

Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene

Department of Biochemistry, School of Dentistry, Showa University (K.M., I.N., N.U., T.T., N.T., T.S.), 1–5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555; Asahi Chemical Industry Company, Ltd., Laboratory for Bone Metabolism (K.K., Y.T., M.H.), 632–1 Mifuku, Ohito-cho, Tagata-gun, Shizuoka 410-2321; Institute of Medical Science University of Tokyo (R.N.), 4–6-1 Shiroganedai, Minato-ku, Tokyo 108-0071; and Department of Orthopaedic Surgery, School of Medicine, Keio University (K.M., Y.T., Y.Y.), 35 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan

Address all correspondence and requests for reprints to: Yasuyuki Takahashi, Asahi Chemical Industry Company, Ltd., Laboratory for Bone Metabolism, 632–1 Mifuku, Ohito-cho, Tagata-gun, Shizuoka 410-2321, Japan. E-mail: a7911076{at}ut.asahi-kasei.co.jp

Subclones of the human osteosarcoma cell line SaOS-2 were established by transfecting with an expression vector containing the human PTH/PTH-related protein (PTHrP) receptor, and their abilities to support osteoclast-like multinucleated cell (OCL) formation were examined in coculture with mouse or human hemopoietic cells. Of four subclones examined, SaOS-2/4 and SaOS-4/3 bound high levels of [¹²⁵I]-PTH and produced a significant amount of cAMP in response to PTH. OCLs were formed in response to PTH in the cocultures of mouse bone marrow cells with either SaOS-2/4 cells or SaOS-4/3 cells. Human OCLs were also formed in response to PTH in the coculture of SaOS-4/3 cells and human peripheral blood mononuclear cells. Adding dexamethasone together with PTH greatly enhanced PTH-induced human OCL formation. Like mouse OCLs, human OCLs formed in response to PTH were tartrate-resistant acid phosphatase positive, expressed abundant calcitonin receptors and vitronectin receptors, and formed resorption pits on dentine slices. Other osteotropic factors such as 1,25-dihydroxyvitamin D₃, prostaglandin E₂, and interleukin 6 plus soluble interleukin 6 receptors failed to induce mouse and human OCLs in cocultures with SaOS-4/3 cells. Both mouse and human OCL formation supported by SaOS-4/3 cells were inhibited by either adding an antibody against macrophage-colony stimulating factor or adding granulocyte/macrophage-colony stimulating factor. Thus, it is likely that human and mouse OCL formation supported by SaOS-4/3 cells are similarly regulated. These results indicate that the target cells of PTH for inducing osteoclast formation are osteoblast/stromal cells but not osteoclast progenitor cells in the coculture. This coculture model will be useful for investigating the abnormalities of osteoclast differentiation and function in human metabolic bone diseases.

This article has been cited by other articles:

				M. Uchiyama, Y. Nakamichi, M. Nakamura, S. Kinugawa, H. Yamada, N. Udagawa, and H. Miyazawa Dental Pulp and Periodontal Ligament Cells Support Osteoclastic Differentiation Journal of Dental Research, July 1, 2009; 88(7): 609 - 614. [Abstract] [Full Text] [PDF]

				Y. Yagi, N. Suda, Y. Yamakoshi, O. Baba, and K. Moriyama In vivo Application of Amelogenin Suppresses Root Resorption Journal of Dental Research, February 1, 2009; 88(2): 176 - 181. [Abstract] [Full Text] [PDF]

				I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation Endocrinology, December 1, 2005; 146(12): 5204 - 5214. [Abstract] [Full Text] [PDF]

				K. Nosaka, T. Miyamoto, T. Sakai, H. Mitsuya, T. Suda, and M. Matsuoka Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappa B ligand on adult T-cell leukemia cells Blood, January 15, 2002; 99(2): 634 - 640. [Abstract] [Full Text] [PDF]

				M. Takami, N. Takahashi, N. Udagawa, C. Miyaura, K. Suda, J.-T. Woo, T. J. Martin, K. Nagai, and T. Suda Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Osteoprotegerin in Osteoblasts Endocrinology, December 1, 2000; 141(12): 4711 - 4719. [Abstract] [Full Text] [PDF]

				T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families Endocr. Rev., June 1, 1999; 20(3): 345 - 357. [Abstract] [Full Text]